NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis
ConditionThumb Osteoarthritis
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age40+
SponsorMayo Clinic
About this trial
The Researchers are trying to compare two different types of intraarticular injections (injection in the joint) for treating the symptoms of moderate to advanced basilar thumb arthritis. One injection is ketorolac (an NSAID) and the other is triamcinolone (a corticosteroid).
Eligibility criteria
Qualifiers
Adults >40 years of age
Pain at the thumb base brought on by direct pressure (grind test) and with movement
Pain resistant to previous conservative management (including over the counter medications (ibuprofen/acetaminophen), icing, splinting/braces, or topical analgesics)
Radiological observation indicative of arthritis based on the Eaton-Littler classification system (stages 1 through 4)
Disqualifiers
• Known allergy to either of the treatment products
Patient's analgesic treatment regimen or other modalities of managing symptoms/pain associated with their hand pathology was modified within four weeks before trial inclusion
Symptomatic Scaphoid-trapezial arthritis present
Localized or systemic infection
Trial design
Treatments tested in this trial
- Ketorolac
- Triamcinolone
Treatment groups
240 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov